Evidence map›Paper›PMID 33199724›Full record

ArticleScientific reports2020

Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives.

Dicky Annas, Se-Yun Cheon, Mohammad Yusuf, Sung-Jin Bae, Ki-Tae Ha, Kang Hyun Park

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Synthesis of [Molecules (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Synthesis and Characterization of Some New Quinoxalin-2(Molecules (Basel, Switzerland) · 2021
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dicky AnnasDepartment of Chemistry, Pusan National University, Busan, 46241, Republic of Korea.
Se-Yun CheonAmcoBio Inc, Seoul, 08758, Republic of Korea.
Mohammad YusufDepartment of Chemistry, Pusan National University, Busan, 46241, Republic of Korea.
Sung-Jin BaeHealthy Aging Korean Medical Research Center and Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, 50612, Republic of Korea.
Ki-Tae HaHealthy Aging Korean Medical Research Center and Department of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan, 50612, Republic of Korea. hagis@pusan.ac.kr.
Kang Hyun ParkDepartment of Chemistry, Pusan National University, Busan, 46241, Republic of Korea. chemistry@pusan.ac.kr.
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is one of the main causes of mortality in the world. Many cancer cells produce ATP through high-level lactic acid fermentation catalyzed by lactate dehydrogenase (LDH), which converts pyruvic acid to lactic acid. LDH plays a dominant role in the Warburg effect, wherein aerobic glycolysis is favored over oxidative phosphorylation. Due to the high lactic acid production level in cancer cells, LDH-targeting could be a potential cancer treatment strategy. A few approaches, such as drug treatment, reportedly inhibited LDH activity. In this study, we describe new 1,3-benzodioxole derivatives that might be potential small molecule candidates for LDHA inhibition. The synthesis was carried out by trans-esterification between aryl ester and alcohol groups from piperonyl alcohol. Compounds 2 and 10 exhibited a selective LDHA IC

Indexed as

Antineoplastic AgentsCell ProliferationDioxolesEnzyme InhibitorsHumansL-Lactate DehydrogenaseNeoplasmsTumor Cells, Cultured1,3-benzodioxoleAntineoplastic AgentsDioxolesEnzyme InhibitorsL-Lactate Dehydrogenase

Identifiers

PMID33199724
PMCPMC7669867
OpenAlexW3103819398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.